Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry R Cutting

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 30, 2010
The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closingMonika Kloch, Michał Milewski, Ewa Nurowska, et al.
Human Mutation|October 28, 2008
Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationshipsKristina V Krasnov, Maria Tzetis, Jie Cheng, et al.
Biomaterials|September 1, 2024
Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungsErin W Kavanagh, Stephany Y Tzeng, Neeraj Sharma, et al.
The Journal of Pediatrics|June 29, 2010
Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung functionJ Michael Collaco, Scott M Blackman, John McGready, et al.
Human Molecular Genetics|December 10, 2014
Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severityDavid L Masica, Patrick R Sosnay, Karen S Raraigh, et al.
The New England Journal of Medicine|August 9, 2002
Variant cystic fibrosis phenotypes in the absence of CFTR mutationsJoshua D Groman, Michelle E Meyer, Robert W Wilmott, et al.
NPJ Digital Medicine|April 8, 2020
Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exerciseDong-Hoon Choi, Grant B Kitchen, Mark T Jennings, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 17, 2020
Predictive effects of low birth weight and small for gestational age status on respiratory and nutritional outcomes in cystic fibrosisSamar E Atteih, Karen S Raraigh, Scott M Blackman, et al.
Pediatric Pulmonology|November 13, 2012
Environmental allergies and respiratory morbidities in cystic fibrosisJoseph M Collaco, Christopher B Morrow, Deanna M Green, et al.
American Journal of Respiratory Cell and Molecular Biology|October 25, 2002
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosisAnabela S Ramalho, Sebastian Beck, Michelle Meyer, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 30, 2010
The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closingMonika Kloch, Michał Milewski, Ewa Nurowska, et al.
Human Mutation|October 28, 2008
Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationshipsKristina V Krasnov, Maria Tzetis, Jie Cheng, et al.
Biomaterials|September 1, 2024
Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungsErin W Kavanagh, Stephany Y Tzeng, Neeraj Sharma, et al.
The Journal of Pediatrics|June 29, 2010
Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung functionJ Michael Collaco, Scott M Blackman, John McGready, et al.
Human Molecular Genetics|December 10, 2014
Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severityDavid L Masica, Patrick R Sosnay, Karen S Raraigh, et al.
The New England Journal of Medicine|August 9, 2002
Variant cystic fibrosis phenotypes in the absence of CFTR mutationsJoshua D Groman, Michelle E Meyer, Robert W Wilmott, et al.
NPJ Digital Medicine|April 8, 2020
Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exerciseDong-Hoon Choi, Grant B Kitchen, Mark T Jennings, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 17, 2020
Predictive effects of low birth weight and small for gestational age status on respiratory and nutritional outcomes in cystic fibrosisSamar E Atteih, Karen S Raraigh, Scott M Blackman, et al.
Pediatric Pulmonology|November 13, 2012
Environmental allergies and respiratory morbidities in cystic fibrosisJoseph M Collaco, Christopher B Morrow, Deanna M Green, et al.
American Journal of Respiratory Cell and Molecular Biology|October 25, 2002
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosisAnabela S Ramalho, Sebastian Beck, Michelle Meyer, et al.
Pageof 16